Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
出版年份 2016 全文链接
标题
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
作者
关键词
T cells, Vaccines, Influenza, Cytotoxic T cells, Influenza viruses, Viral vaccines, Antigens, Immune response
出版物
PLoS One
Volume 11, Issue 8, Pages e0161193
出版商
Public Library of Science (PLoS)
发表日期
2016-08-16
DOI
10.1371/journal.pone.0161193
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice
- (2015) Wenling Wang et al. Clinical and Vaccine Immunology
- Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
- (2014) Raquel P Deering et al. Expert Opinion on Drug Delivery
- A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus
- (2014) D. M. Carragher et al. JOURNAL OF IMMUNOLOGY
- The Influenza Virus-Specific CTL Immunodominance Hierarchy in Mice Is Determined by the Relative Frequency of High-Avidity T Cells
- (2014) T. Cukalac et al. JOURNAL OF IMMUNOLOGY
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
- (2014) Luis A Brito et al. MOLECULAR THERAPY
- MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
- (2014) Annett Hessel et al. PLoS One
- Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
- (2014) C. Maisonneuve et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
- (2014) Arwen Altenburg et al. Viruses-Basel
- Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine
- (2013) Caitlin E. Mullarkey et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
- (2013) Teresa Lambe et al. Scientific Reports
- Cross-protection against drifted influenza viruses
- (2013) Andrea Orsi et al. Human Vaccines & Immunotherapeutics
- Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
- (2013) Armin Hekele et al. Emerging Microbes & Infections
- Lack of Interference with Immunogenicity of a Chimeric Alphavirus Replicon Particle-Based Influenza Vaccine by Preexisting Antivector Immunity
- (2012) Yasushi Uematsu et al. Clinical and Vaccine Immunology
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza
- (2012) Giuseppe Del Giudice et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
- (2012) Daniel X. Johansson et al. PLoS One
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Return of inactivated whole-virus vaccine for superior efficacy
- (2011) Yoichi Furuya IMMUNOLOGY AND CELL BIOLOGY
- TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection
- (2011) I. Jelinek et al. JOURNAL OF IMMUNOLOGY
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
- (2011) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
- Protective Efficacy of Seasonal Influenza Vaccination against Seasonal and Pandemic Influenza Virus Infection during 2009 in Hong Kong
- (2010) Benjamin J. Cowling et al. CLINICAL INFECTIOUS DISEASES
- Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
- (2010) T. K. Berthoud et al. CLINICAL INFECTIOUS DISEASES
- New flow cytometric assays for monitoring cell-mediated cytotoxicity
- (2010) Liubov Zaritskaya et al. Expert Review of Vaccines
- Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
- (2010) Filippo Ansaldi et al. VACCINE
- Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines
- (2009) Arnold S. Monto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterosubtypic immunity to influenza A virus: where do we stand?
- (2008) Kristie M. Grebe et al. MICROBES AND INFECTION
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Epitope-specific TCR repertoire diversity imparts no functional advantage on the CD8+ T cell response to cognate viral peptides
- (2008) N. L. La Gruta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus
- (2008) Quanjiao Chen et al. VIRUS GENES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search